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ABSTRACT
The mammalian mitochondrial transcription termi-
nation factor mTERF binds with high affinity to a
site within the tRNALeu(UUR) gene and regulates
the amount of read through transcription from the
ribosomal DNA into the remaining genes of the
major coding strand of mitochondrial DNA (mtDNA).
Electrophoretic mobility shift assays (EMSA) and
SELEX, using mitochondrial protein extracts from
cells induced to overexpress mTERF, revealed
novel, weaker mTERF-binding sites, clustered in
several regions of mtDNA, notably in the major non-
coding region (NCR). Such binding in vivo was
supported by mtDNA immunoprecipitation. Two-
dimensional neutral agarose gel electrophoresis
(2DNAGE) and 5’ end mapping by ligation-mediated
PCR (LM-PCR) identified the region of the canonical
mTERF-binding site as a replication pause site. The
strength of pausing was modulated by the expres-
sion level of mTERF. mTERF overexpression also
affected replication pausing in other regions of
the genome in which mTERF binding was found.
These results indicate a role for TERF in mtDNA
replication, in addition to its role in transcription.
We suggest that mTERF could provide a system
for coordinating the passage of replication and
transcription complexes, analogous with replication
pause-region binding proteins in other systems,
whose main role is to safeguard the integrity
of the genome whilst facilitating its efficient
expression.
INTRODUCTION
The mitochondrial genome of animals is organized in a
highly compact manner, with virtually no non-coding
information between or within its 37 genes. The circular
genome is transcribed by a phage-type RNA polymerase
into polycistronic transcripts which, in mammals, encom-
pass the entire genome on both strands (1,2). Production
of these transcripts depends upon a set of closely spaced
promoters located in the major non-coding region (NCR).
The primary transcripts are then processed to mature
mRNAs, rRNAs and tRNAs via a series of enzymatic
steps requiring the tRNA-processing endonucleases
RNase P and tRNAse Z, as well as other enzymes. The
major coding strand (informationally the L-strand, but for
the purposes of transcription conventionally referred to by
the name of the template, H-strand) is transcribed
from two distinct initiation sites at the heavy-strand
promoter (HSP), PH1 and PH2, separated by 100 bp. The
PH2-derived precursor transcript covers virtually the entire
genome and can give rise to all of the transcription
products of the heavy-strand except tRNAPhe, whose
coding sequence overlaps the PH2 initiation site. The
PH1 initiation site gives rise to a truncated transcript
encompassing just the rRNAs (plus two tRNAs) and thus
deﬁnes a distinct mitochondrial rDNA transcription unit.
Termination at the 30 end of the rDNA is brought about
by a transcription termination factor, mTERF (3–6),
which has also been proposed to interact with the RNA
polymerase in initiation site selection (2,7). Recent data
suggest that this involves formation of a DNA loop in
which RNA polymerase complexes are recycled around
the rDNA segment of the genome after terminating (7).
mTERF binds sequence speciﬁcally with high aﬃnity to a
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sequence element within the coding sequence of
tRNALeu(UUR), located immediately downstream of the
rDNA (4). Current evidence indicates that mTERF
interacts with its asymmetric-binding site as a monomer
(8), although the tertiary structure of the protein and the
structural basis of its interaction with DNA are unknown.
mTERF belongs to a recently identiﬁed superfamily of
proteins whose functions are largely unknown (9–11).
Homologues in Drosophila and in sea urchins have
variously been implicated in transcriptional termination
(12–14), regulation of DNA replication (15) and even
mitochondrial protein synthesis (11). The sea urchin
mTERF homologue mtDBP (D-loop-binding protein)
has recently been shown to terminate transcription in a
polar manner (14,16), analogous with the activity of
mTERF (5). However, mtDBP is also a contrahelicase
(15), and has been proposed to play a role in regulating
the expansion of the short D-loop of sea urchin mtDNA
and thus the initiation of productive replication of the
genome.
Transcription and replication of mtDNA have long
been regarded as interlinked processes. The primer for
initiation of DNA replication has been assumed to be a
product of transcription by the mitochondrial RNA
polymerase. However, there is no consensus concerning
the mechanism by which 30 ends are generated for
extension by DNA polymerase, variously proposed to be
RNA processing by endonuclease MRP (17) or protein-
independent termination at one of the conserved sequence
blocks of the NCR (18). The exact site of replication
initiation is also unclear, and may vary between cell-types.
A prominent cluster of 50 ends in H-strand DNA,
designated as OH, is generally regarded as the major
origin of (unidirectional) replication. However, there is no
direct experimental evidence that it functions thus, and
bidirectional initiation clearly occurs in some molecules at
sites downstream of OH, both in cultured cells (19),
especially when recovering from drug-induced mtDNA
depletion (20), and in solid tissues (21,22). In a minority of
molecules (21) these initiation sites can encompass the
entire genome (in birds) or almost the entire genome
(in mammals).
Mitochondrial DNA (mtDNA) was for over 25 years
assumed to replicate by a unique, strand-asynchronous
mechanism (23). However, more recent analysis of
mtDNA replication intermediates (RIs) by two-
dimensional neutral agarose gel electrophoresis
(2DNAGE) failed to detect the extensively single-stranded
products of such a replication mechanism (19–22,24–26)
and instead revealed two classes of double-stranded RIs.
One class consists of the predicted products of conven-
tional strand-coupled replication (19,21,24,25); the other
contains extended RNA segments (26) encompassing the
entire lagging strand (RITOLS, ‘RNA incorporation
throughout the lagging strand’, 19). Maturation of the
lagging strand to DNA appears to occur with diﬀerent
kinetics and distinct sites of initiation in diﬀerent
organisms (19), and some RIs of the ﬁrst class could be
interpreted as molecules in which lagging-strand DNA
synthesis has eﬀectively caught up with the advancing
fork, as a result of replication pausing. The mechanism by
which the RNA lagging strand is created is unknown.
mtDNA replication also depends on the HMG-box
protein TFAM, named for its essential role as a cofactor
for eﬃcient and speciﬁc transcriptional initiation. TFAM
is required for mtDNA maintenance (27) and appears to
have several distinct roles in mtDNA metabolism. It is a
major structural protein of the mitochondrial chromo-
some, but also inﬂuences mtDNA replication in ways
connected with transcription. Overexpression of TFAM
leads to a drop in mitochondrial transcript levels and a
pronounced shift toward conventional, strand-coupled
RIs (28). This could represent either a general slowing or
stuttering of fork advance, attributable to a decreased
availability of RNA to form the lagging strand (i.e. in
which lagging-strand maturation frequently catches up
with fork advance) or else a programmed switch to
standard DNA synthesis.
As a factor aﬀecting the outcome of mitochondrial
transcription, mTERF might be expected also to have
some inﬂuence over mtDNA replication if, as suggested,
replication is intimately connected with transcription.
We therefore embarked on a series of experiments to
document the eﬀects on mtDNA replication of modulat-
ing the expression of mTERF in cultured human cells.
To this end, we set out initially to characterize better the
binding speciﬁcity of mTERF, especially given recent
reports of possible additional binding sites for mTERF
in vivo (6,29). Electrophoretic mobility shift assays
(EMSA) using mitochondrial protein extracts from cells
induced to overexpress mTERF revealed additional,
though weaker mTERF-binding sites clustered in strate-
gically important regions of the mitochondrial genome.
2DNAGE and lagging strand 50 end mapping by ligation-
mediated PCR (LM-PCR) identiﬁed the canonical
mTERF-binding site as a replication pause site, with the
frequency of pausing subject to the expression level of
mTERF. Replication pausing in other regions of the
genome, notably the NCR, was also aﬀected by mTERF
overexpression. These results indicate a role for mTERF
in mtDNA replication, in addition to its role in
transcription.
MATERIALS AND METHODS
Cells and cell culture
Human embryonic kidney-derived HEK293T cells, Flp-
InTM T-RexTM-293 cells (Invitrogen), 143B osteosarcoma,
Jurkat and HeLa cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM, Sigma) containing
4.5 g/l of D-glucose, 10% foetal calf serum (Sigma),
50 mg/ml uridine (Sigma) and 2mM L-glutamine
(BioWhittaker/Cambrex) at 378C in an incubator with
5% CO2 in air. Flp-In
TM T-RexTM-293-derived cell-lines
were cultured under selection with blasticidin and
hygromycin according to the manufacturer’s protocol.
Expression of mTERF or mTERF-MycHis (C-terminally
tagged) was induced in transfected Flp-InTM T-RexTM-
293 cells with 10 ng/ml doxycyclin (Sigma-Aldrich), which
was replenished every 48 h. Cells were passaged routinely
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every 3–4 days at 1:10 or 1:20 dilution. Adherent cells were
detached either by pipetting alone or, for HeLa cells, by
treatment with Trypsin-EDTA (Bio-Whittaker/Cambrex).
Suspension cells (Jurkat) were passaged by centrifugation
and resuspension in fresh medium.
Oligonucleotides and plasmids
Oligonucleotides used to create EMSA or hybridization
probes by PCR from puriﬁed human mtDNA or cloned
segments thereof are listed in Supplementary Table 1. The
mTERF coding region, including the mitochondrial
targeting signal and 24 nt of the 50 untranslated region, a
total of 1221 bp, was ampliﬁed from HeLa cell cDNA (30)
using the following chimeric primer pairs (all sequences
shown 50 to 30, restriction sites used for cloning under-
lined): BamHI-mTERF F1, CGCGGATCCCTGTTCTC
CAGCCTTTCTGG plus HindIII-mTERF R1, CCC
AAGCTTGGCAAATCTGCTTAACTTTTT to create
an in-frame C-terminal fusion to the Myc epitope tag;
BamHI-mTERF F1 plus HindIII-mTERF R STOP,
CCCAAGCTTTCAGGCAAATCTGCTTAACTTTTTC
to create an mTERF expression construct containing the
stop codon at the natural position (shown in italics,
underlined, complementary strand). After sequence
veriﬁcation PCR products were digested with BamHI
and HindIII (Fermentas, manufacturer’s recommended
conditions) and ligated to similarly digested pcDNA3.1(-)/
Myc-His A (Invitrogen) vector DNA to create the
mTERF and mTERF-MycHis expression constructs.
For induced expression using the Flp-InTM T-RExTM-
293 cell system these plasmids were digested with PmeI
(New England Biolabs), which cuts on either side of the
insert, ligated into PmeI-digested DNA of the vector
pcDNA5/FRT/TO (Invitrogen), and stably transfected
into the recipient cells as previously (31).
DNA and siRNA transfections
HEK293T cells were transfected either with 3 mg of
plasmid DNA and 30 ml of LipofectAMINE (Invitrogen)
or 10 mg of DNA and 40 ml of TransFectinTM Lipid
Reagent (Bio-Rad), according to manufacturers’ proto-
cols. Transiently transfected cells were subsequently
harvested for diﬀerent assays, or placed under selection
using 2mg/ml G418 Sulfate (Calbiochem), in order to
select clones of stably transfected cells expressing
mTERF-MycHis. mTERF-speciﬁc siRNAs were synthe-
sized by means of in vitro transcription using the
SilencerTM siRNA construction kit (Ambion). Candidate
target sites for speciﬁc mTERF silencing were chosen
using a prediction programme provided by Ambion
(http://www.ambion.com/techlib/misc/siRNA_ﬁnder.html).
One out of ﬁve tested siRNAs was found to be eﬃcient
in mTERF silencing (see Results section), the relevant
target site in mTERF mRNA being nt 585–605
(50-AAGCGGGUGAAAGCUAACAUU-30). To knock-
down mTERF expression, HEK293T cells (with or with-
out prior stable transfection with the mTERF-MycHis
expression construct) were transfected with 10 nM (ﬁnal
concentration) of mTERF-speciﬁc siRNA molecules using
LipofectamineTM 2000 transfection reagent (Invitrogen),
as per manufacturer’s recommendations. An siRNA
reagent targeted on 50-GGAGAAGGUACGAGGGGC
AUU-30 (siRNA Control) was used as a negative control.
Immunocytochemistry
For immunocytochemistry cells were grown on coverslips,
seeded at low density. Twenty-four hours after transfec-
tion or induction with doxycyclin, cells were washed with
DMEM and then incubated in fresh medium containing
100mMMitoTracker Red CMXRos (Molecular Probes)
at 378C for 10min, then washed twice with PBS. After
incubation in fresh medium at 378C for 2 h, cells were
again washed twice with PBS and ﬁxed in 4% formalde-
hyde/5% sucrose in PBS at 378C for 15min. After three
further PBS washes cells were permeabilized by incubation
in 0.5% Triton X-100 in PBS at 378C for 15min, washed
twice with PBS, incubated in blocking solution (5% w/v
non-fat milk powder in PBS) at room temperature for
45min, then again washed three times with PBS. After
incubation in primary antibody solution, mouse anti-
Myc monoclonal 9E10 (Roche Molecular Biochemicals,
stock 5mg/ml) 1:1000 in PBS for 1 h at room temperature,
cells were washed three times with PBS, then incubated
for 1 h at room temperature in a 1:200 dilution of
secondary antibody, ﬂuorescein-conjugated horse anti-
mouse IgG (Vector Technologies, stock 1.5mg/ml). After
three ﬁnal PBS washes the coverslips were mounted on
slides using Vectashield with DAPI (Vector Technologies).
Cells were visualized and photographed using an Olympus
IX70 inverted confocal microscope at 100 magniﬁcation,
with excitation at 568 nm (emission 607/45) for
Mitotracker Red and 488 nm (emission 525/50) for
ﬂuorescein, using an Andor iXon DV885 front-illumi-
nated CCD camera.
Western blotting
SDS–PAGE used 12% polyacrylamide gels under stan-
dard conditions (32). Protein extraction and western
blotting were carried out essentially as described pre-
viously (30). Primary antibodies used were mouse anti-
Myc monoclonal 9E10 (as above, diluted 1:15000) and
rabbit anti-human mTERF antibody, custom-supplied
(Invitrogen) as an anti-peptide (KLH-conjugated
CSNDYARRSYANIKE) antibody, 1mg/ml, diluted
1:5000. Kodak BiomaxTM ML X-ray ﬁlm was exposed
to the ﬁlter membrane for between 5 s and 5min.
Preparation of mitochondrial lysates
Cells were harvested without trypsinization, resuspended
in 1ml (per 10 cm plate of cells) of resuspension buﬀer
(0.133M NaCl, 5mM KCl, 0.7mM Na2HPO4, 25mM
Tris–HCl pH 7.5) and centrifuged at 1200gmax for 2min at
48C. The pellet was resuspended in 0.5ml of swelling
solution (10mM NaCl, 1.5mM CaCl2, 10mM Tris–HCl
pH 7.5) and incubated on ice for 15min. After swelling,
the cells were dounce-homogenized (20–25 strokes, tight-
ﬁtting pestle) on ice and breakage of the cells was checked
microscopically. An equal volume of sterile ﬁltered
sucrose/EDTA buﬀer (0.68M sucrose, 2mM EDTA,
20mM Tris–HCl pH 7.5) was added immediately after
6460 Nucleic Acids Research, 2007, Vol. 35, No. 19
breaking the cells. Nuclei and debris were pelleted
by centrifugation at 1200gmax for 10min at 48C. The
supernatant was transferred to a fresh tube and centrifu-
gation was repeated. The supernatant was collected and
recentrifuged at 16 000gmax for 30min at 48C. The
mitochondrial pellet was washed once with 200 ml of
PBS and frozen at 808C or lysed immediately. For
processing large quantities of cells the volumes were scaled
up. Mitochondrial lysates were prepared essentially as
described by Fernandez-Silva et al. (33), except using
‘Complete, Mini protease inhibitor cocktail’ (Roche)
instead of PMSF.
EMSA
DNA fragments for EMSA were PCR ampliﬁed using
mtDNA as template and primer pairs shown in
Supplementary Table 1, followed by sequence veriﬁcation
of the product. dsDNA oligonucleotide probes for EMSA
(Supplementary Table 1) were prepared by mixing equal
amounts of complementary oligonucleotide pairs in 500 ml
of H2O to a ﬁnal concentration of 2mM, followed by
incubation for 5min at 1008C and cooling to room
temperature on the bench. Total of 300 ng of each PCR
fragment or 20 pmol of each dsDNA oligonucleotide
were labelled using 8U of T4 polynucleotide kinase
(Fermentas) and 15 mCi of [g-32P] ATP (Amersham
Pharmacia Biotech, 3000Ci/mmol) in 15 ml ﬁnal volume
of PNK buﬀer (MBI Fermentas). Reactions were stopped
on ice and diluted to 100ml with H2O. EMSA was carried
out in 20 ml binding reactions according to Fernandez-
Silva et al. (33) with minor modiﬁcations. Reactions
contained at least 10 ml of the binding buﬀer (25mM
HEPES–KOH, pH 7.5, 12.5mM MgCl2, 20% glycerol,
0.1% Tween-20, 1mMDTT), 0.2 pmol of labelled dsDNA
oligonucleotide or 3 ng of labelled PCR product as probe,
5 mg of mitochondrial lysate, 100mM KCl, 5 mg BSA and
5 mg of non-speciﬁc competitor DNA poly(dI-dC)–(dI-dC)
(Amersham Pharmacia Biotech). Reactions were incu-
bated at room temperature for 20min and terminated on
ice with addition of 0.25 volumes of 30% glycerol.
Competition EMSA reactions contained also up to
100-fold excess of the non-labelled competing probe.
Supershift EMSA reactions contained 0.5mg of anti-Myc
antibody (as above), or 1 mg of anti-FLAG M2 antibody
(Sigma), which was added 30min prior to the labelled
probe. Depending on the length of the fragment, reaction
products were analysed on 5–10% non-denaturing poly-
acrylamide TBE gels, pre-run at 48C in 2.2 TBE at 100V
for 1 h at 48C, then run at 100V for 30min and 175V for
3–5 h depending on the size of the probe fragment. Gels
were dried and autoradiographed using KODAK
BioMaxTM MS ﬁlm.
SELEX
Creation of a randomized DNA ligand library was carried
out essentially as described by Blackwell (34). The 46 nt
long oligonucleotide template contained 14 internal
random nucleotides, ﬂanked on either side by 16 nt ﬁxed
ends corresponding with standard primers, containing
recognition sites for BamHI and EcoRI, respectively.
Second-strand synthesis was carried out in a reaction
volume of 20 ml containing 1.6 mg of template, 500 mmol of
primer, 2mM dNTPs and 5U of Klenow fragment
(Fermentas) in Klenow fragment buﬀer at 468C for
1min, followed by 378C for 7.5min. The reaction was
stopped by heating at 758C for 10min and the dsDNA
ligand library was gel-puriﬁed from an EtBr-stained 14%
native polyacrylamide gel using the QIAEX kit
(QIAGEN) according to the manufacturer’s protocol.
Ligand selection was carried out in 25 ml reactions under
essentially the same conditions as EMSA, using 10 mg of
mitochondrial protein lysate from mTERF-MycHis
expressing Flp-InTM T-RexTM-293-cells, 0.8 mg of the
ligand DNA and 6.25 mg of non-speciﬁc competitor
DNA poly(dI-dC)–(dI-dC) incubated for 20min at room
temperature. Pre-swollen anti-myc-Sepharose beads
(Amersham Biosciences) were suspended in EMSA
buﬀer (25mM HEPES–KOH, pH 7.5, 12.5mM MgCl2,
20% glycerol, 0.1% Tween-20, 1mM DTT, 100mM KCl,
0.2mg/ml BSA), washed once in the same buﬀer and
resuspended in 1.5 volumes of the same buﬀer containing
0.25mg/ml poly(dI-dC)–(dI-dC). To each binding reaction
was added 100 ml of the bead suspension, followed by
gentle rotation for 2 h at 48C. Beads were then washed in
EMSA buﬀer containing 0.25 mg/ml poly(dI-dC)–(dI-dC),
followed by a further seven times in the buﬀer without
poly(dI-dC)–(dI-dC) and gentle rotation overnight in
100 ml of K buﬀer (10mM Tris–HCl, 0.5mM EDTA
50mM NaCl, pH 8.0) containing 100 mg/ml of freshly
dissolved proteinase K (Fermentas). DNA was recovered
from the beads by extraction with phenol–chloroform–
isoamyl alcohol (25:24:1) and ethanol precipitation,
washed once with 70% ethanol and resuspended in a
minimal volume of H2O (7.5 ml). PCR was then carried
out using 2 ml of this template in a 50 ml reaction volume
containing 0.2 mM of each SELEX primer (GGTGAAT
TCGCTCACG and GAACGGATCCCTTTCG, both
shown 50 to 30, with restriction sites for cloning under-
lined) and 2.5U of Pfu DNA polymerase (Promega).
Thirty ampliﬁcation cycles were carried out using a 15 s
extension step, after which the enriched ligand DNA was
gel-puriﬁed from an EtBr-stained 12% native polyacryl-
amide gel as above. After seven such enrichment cycles,
the ligand DNA was cloned into pCR4Blunt-TOPO
vector (Invitrogen) and individual clones were sequenced
using standard primers on an ABI 3100 sequencer using
the BigDye Terminator v3.1 cycle sequencing kit
(Applied Biosystems).
DNA extraction and mtDNA copy number estimation
For the preparation of mtDNA (mitochondrial nucleic
acids) for analysis of RIs from cultured cells, mitochon-
dria were isolated and processed as described by
Pohjoisma¨ki et al. (28). Total DNA for analysis of
mtDNA copy number was extracted from cells by stan-
dard methods (35), and copy number was determined
using quantitative PCR, as described previously (28), with
amyloid precursor protein (APP) as a single-copy nuclear
DNA standard. Human placental mtDNA was prepared
as previously (24). Total DNA for analysis of mtDNA RIs
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was extracted from frozen human tissue blocks 7  7 
7mm3) obtained via forensic autopsies. The samples
were taken as part of the Tampere Coronary Study,
approved by the Ethics Committee of Tampere University
Hospital (DNO 1239/32/200/01) and the National
Authority for Medicolegal Aﬀairs. Heart, brain, skeletal
muscle and kidney tissue samples were cut into thin slices
with a sterile blade and suspended in 2ml DNA extraction
buﬀer (28). One-tenth volume of 10% SDS and 0.5mg
proteinase K were added. The crude homogenate was
passed several times through a 5ml pipette tip with a
sawn-oﬀ end, to disperse the larger tissue fragments.
The homogenate was incubated overnight with gentle
swirling at 378C. After incubation, 2 volumes of phenol–
chloroform–isoamylalcohol (25:24:1) were added, and the
mixture was shaken gently for 1 h. The mixture was then
transferred to Eppendorf 15ml Phase Lock GelTM Heavy
tubes and centrifuged at 5000gmax for 15min. The aqueous
phase was recovered and the extraction step repeated.
DNA was precipitated by the addition of 0.2 volumes of
10M ammonium acetate and 2 volumes of ethanol. The
mixture was incubated on ice for 10min and DNA was
spooled out using a glass rod, washed once with 70%
ethanol, air dried gently and resuspended in 300–700ml TE
buﬀer (10mM Tris–HCl, 1mM EDTA, pH 8.0), depend-
ing on the pellet size. 2DNAGE analysis used 10 mg
aliquots of heart and brain DNA and 20 mg aliquots of
kidney and skeletal muscle DNA.
Two-dimensional neutral agarose gel electrophoresis
One microgram of total mitochondrial nucleic acids was
used per analysis. Restriction digestions were performed
following manufacturers’ recommendations, except for
BclI which was carried out at 378C for double the usual
reaction time. If subsequent treatment with S1 nuclease
was used, DNA was ﬁrst recovered by ethanol precipita-
tion and resuspended in the appropriate reaction buﬀer,
before treatment with 50U S1 Nuclease (Promega) for
30 s. Reactions were stopped by the addition of an equal
volume of phenol–chloroform–isoamyl alcohol (25:24:1,
pH 8.0) and immediately extracted. 2DNAGE was
performed as described previously [(28), note diﬀerent
gel conditions for fragments in diﬀerent size classes).
Radiolabelled probes and blot hybridization
For Southern hybridization, probes were created by
Pfu-PCR, using cloned segments of human mtDNA as
template (see Supplementary Table 1), and subse-
quently sequenced to conﬁrm their identity. Probes were
labelled using RediprimeTM II random prime labelling
kit (Amersham) and [a-32P] dCTP (Amersham;
3000Ci/mmol).
LM-PCR
LM-PCR was carried out as described by Yasukawa et al.
(20), using oligonucleotide primer sets as indicated in
ﬁgure legends and as detailed in Supplementary Table 2.
Mitochondrial DNA immunoprecipitation
Cells were processed for mitochondrial DNA immuno-
precipitation (mIP) essentially as described by Lu et al.
(36). The mtDNA was sheared to fragments of average
size 500–600 bp using a Sonics Vibra-Cell sonicator, 3mm
tip at 25% power for 3 20 s (1 s on, 1 s oﬀ) with
incubation on ice for 30 s between. Complete, Mini
protease inhibitor cocktail (Roche) was included in the
lysis buﬀer. Lysates were pre-cleared with pre-swollen
Protein A Sepharose (Amersham Biosciences) and immu-
noprecipitations were carried out with 5 mg mouse anti-
Myc monoclonal 9E10 (Roche Molecular Biochemicals)
or anti-FLAG M2 antibody (Sigma) overnight at 48C.
Final PCR reactions used primers listed in Supplementary
Table 1 and the minimum number of ampliﬁcation cycles
required to generate substantial product bands from the
input DNAs (generally 25–26 cycles, depending on the
fragment, based on preliminary tests), thus avoiding
saturation.
RESULTS
mTERF has multiple binding sites in the human
mitochondrial genome
In order to study the eﬀects of mTERF on mtDNA
replication, we established HEK293-derived cells expres-
sing both natural mTERF and C-terminally Myc epitope-
tagged mTERF. Mitochondrial targeting was veriﬁed
by immunocytochemistry of transiently transfected
HEK293T cells expressing mTERF-MycHis (Figure 1a).
Induction of protein expression in Flp-InTM T-RexTM-293
cells stably transfected with the mTERF or mTERF-
MycHis constructs was veriﬁed by western blotting
(Figure 1b). Protein levels were the same after 24 or 48 h
of induction. Prolonged overexpression of mTERF
(6 days) had no signiﬁcant eﬀect on mtDNA copy
number as estimated by Southern blotting (data not
shown) or by quantitative PCR (Supplementary
Figure 1a).
Since the main aim of the study was to determine the
eﬀects of altered mTERF expression on mtDNA replica-
tion in vivo, we ﬁrst tested the eﬀects of mTERF
expression on protein binding to mitochondrial DNA,
using EMSA with mitochondrial protein extracts from
cells overexpressing mTERF. In contrast to earlier studies
using puriﬁed, bacterially expressed mTERF, this tests the
eﬀects of altered mTERF expression level on protein–
DNA interactions in the mitochondrial milieu, in which
other mitochondrial proteins, including TFAM, are
present and may inﬂuence binding.
Using EMSA with probes covering the previously
identiﬁed, canonical mTERF-binding site in the
tRNALeu(UUR) gene, we conﬁrmed that overexpression
of natural mTERF, whether by transient or stable
transfection (data not shown), or under tetracycline
induction (Figure 1c), leads to a large increase in
sequence-speciﬁc binding activity. The protein complex
formed from the Myc epitope-tagged protein migrated
slightly slower than the complex formed by endogenous
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or overexpressed natural mTERF, and was supershifted
by an anti-Myc monoclonal antibody (Figure 1c), but not
by other antibodies (e.g. anti-FLAG, Supplementary
Figure 1b). The anti-Myc antibody did not supershift
the complex formed by endogenous or overexpressed
natural mTERF (Supplementary Figure 1b).
These properties next allowed us to test other regions of
the mitochondrial genome for speciﬁc binding of mTERF
to DNA, using EMSA. Using overlapping fragments of
150 bp, we scanned the major NCR and its ﬂanking
sequences, the minor NCR (OL), its surrounding tRNA
gene cluster, the region extending from OL to the
canonical mTERF-binding site in the tRNALeu(UUR)
gene, the ATPase 6 gene and its junction with the COIII
gene and several other segments of the genome (Figure 2,
Supplementary Figures 2 and 3). We estimated relative
binding aﬃnities using competition EMSA against the
tRNALeu(UUR) gene fragment and vice versa. As shown in
Figure 2 and Supplementary Figure 2, we identiﬁed a
cluster of four moderately strong mTERF-binding sites
within the ND1 coding sequence and the adjacent IQM
tRNA gene cluster (see Figure 2e for summary).
Competition EMSA indicated that the binding to frag-
ment ND1.1 (Figure 2b) was between one and two orders
of magnitude weaker than to the canonical binding site
in tRNALeu(UUR). Binding to the ND1.1 fragment was
tested further, using shorter, overlapping fragments
(Supplementary Figure 2d). The results suggest that
fragment ND1.1 contains two distinct binding sites.
We also identiﬁed a binding site adjacent to OH (fragment
OH1) at least two orders of magnitude weaker than the
canonical binding site, based on competition EMSA data
(data not shown), as well as four other binding sites in the
D-loop portion of the NCR and one at OL, plus a possible
site at the HSP (fragment OH5, see Supplementary
Figure 2e).
Alignment of the sequences of these binding sites
suggested a consensus which was veriﬁed by SELEX
(Table 1). Most of the SELEX output clones analysed
(82/109) contained at least one match to the consensus
TGGT or TYGGT, and 43 clones showed an identical or
almost identical (8/9) match to the extended consensus
TGGT(N5)TYGGT (or its complement). Of 28 control
clones analysed, subjected to the same number of
ampliﬁcation cycles but without antibody selection, none
matched this consensus. Comparing the SELEX consen-
sus with the canonical mTERF-binding site in the
tRNALeu(UUR) gene, and with the ﬁndings of an earlier
application of PCR-based selection on a smaller scale
using only EMSA (37), the invariant features of the
binding site would appear to be two pairs of G residues on
the same strand, separated by eight nucleotides (see also
Supplementary Table 3).
In order to verify that mTERF is able to bind to at least
some of its non-canonical binding sites in vivo, we carried
out semi-quantitative mIP, using a minor adaptation of
the method recently published by Lu et al. (36). For this
assay we used cells inducibly expressing mTERF-MycHis,
and carried out immunoprecipitation using anti-Myc
antibody, as well as a control antibody (anti-FLAG) or
no antibody.
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F
Figure 1. Overexpression of mTERF in cultured cells. (A) Immunocy-
tochemistry of HEK293T cells transiently or stably transfected with
mTERF-MycHis, using anti-Myc monoclonal antibody, counterstained
with Mitotracker Red. (B) Western blots of mitochondrial protein
extracts from Flp-InTM T-RExTM-293 cells transfected with the
mTERF or mTERF-MycHis constructs and induced for expression as
indicated (0, 24, 48 h) or from transiently transfected (t) HEK293T
cells, probed with anti-Myc or anti-mTERF antibodies, as indicated.
The endogenous mTERF protein detected by the anti-mTERF
antibody is singly arrowed. The mTERF-MycHis fusion protein
detected by the same antibody is indicated by a double arrow.
(C) EMSA using Leu-short dsDNA oligonucleotide probe and
mitochondrial protein extracts from Flp-InTM T-RExTM-293 cells
transfected with the mTERF or mTERF-MycHis constructs and
induced for expression as indicated. EMSA was carried out with or
without anti-Myc antibody as shown (left-hand panel), or (right-hand
panel) in the presence of an increasing amount of cold Leu-short
dsDNA oligonucleotide competitor (1-, 10-, 100- and 1000-fold mass
excess) or without competitor (). The free probe (F), complexes
formed by natural mTERF (BN) or the mTERF-MycHis fusion protein
(BF), and the antibody-supershifted complex (S) are indicated. See also
Supplementary Figure 1.
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Figure 2. EMSA and mIP analysis of alternate mTERF-binding sites in human mtDNA. (A) Schematic diagram of regions of the mitochondrial
genome in which binding was detected, showing NCR (white box), 16S and 12S rRNA genes (pale grey boxes), protein-coding genes ND1, ND2,
COI and cyt b (darker grey boxes), tRNA genes (cross-hatched boxes), OH, OL and the promoters/transcriptional initiation sites of the two strands
(PL, PH1 and PH2). Genes transcribed to the right shown above the centre line, genes transcribed to the left shown below. Nucleotide coordinates are
as Ref. (82). Black bars indicate the positions of the 150 bp probe fragments which were found by EMSA to contain strong or moderate binding sites
for mTERF, as shown in panels b and c. (B) Competition EMSA using the probes and competitors as shown, plus mitochondrial protein extract
from cells induced to express mTERF-MycHis. The amounts of cold competitor represent 1-, 10- and 100-fold mass excess over the probe. Similar
results were obtained using extracts from cells overexpressing natural mTERF (data not shown). (C) EMSA analyses of binding to 150 bp probe
fragments as indicated, using mitochondrial protein extracts from Flp-InTM T-RExTM-293 cells transfected either with natural mTERF or with
mTERF-MycHis (mTERF-mh) and induced for expression (or not) as indicated. Supershifting with the anti-Myc monoclonal antibody was
performed for the lanes indicated. Supershifted complexes are denoted by arrows. Although the supershifted complex is minor in some cases, the
main complex is always eﬃciently removed by the antibody, conﬁrming the presence of mTERF-MycHis. Other antibodies tested (e.g. anti-FLAG)
gave no supershifting and did not inhibit the formation of these complexes. For further experiments conﬁrming speciﬁcity of binding and negative/
weak ﬁndings using other fragments, see Supplementary Figures 1 and 2. (D) mIP analysis of mTERF-MycHis binding in vivo. Immunoprecipitation
used anti-Myc (M), anti-FLAG (F) or no antibody (). Ampliﬁcation of immunoprecipitates alongside corresponding input DNAs used the same
primer pairs as were employed to generate the corresponding fragments for EMSA (see Supplementary Table 1), Samples were from Flp-InTM
T-RExTM-293 cells induced for mTERF-MycHis expression, except for fragment Leu, where extracts from uninduced cells were also tested.
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Induction of mTERF-MycHis expression enabled
immunoprecipitation of several key fragments of the
mitochondrial genome in which binding was found
in vitro (Figure 2d) The fragment containing the canonical
mTERF-binding site in the tRNALeu(UUR) gene was
routinely detected in the anti-Myc immunoprecipitate
from induced cells, but was not immunoprecipitated
by control antibody (anti-FLAG) or no antibody.
Immunoprecipitates from uninduced cells were negative
under comparable conditions, but using excess anti-Myc
antibody we sometimes observed weak ampliﬁcation of
this fragment (data not shown), consistent with a low level
of leaky expression of the mTERF-MycHis transgene and
the high aﬃnity of the protein for the canonical binding
site. Consistent positive signals were also seen in the anti-
Myc immunoprecipitate from induced cells, but not
control immunoprecipitates, for the HSP-containing frag-
ment OH5 and for the three D-loop fragments (NCR1,
NCR5 and OH1) which gave the strongest EMSA signals
in vitro (Figure 2c). The ND1.1 fragment internal to
the ND1 coding sequence was also weakly ampliﬁed
from anti-Myc immunoprecipitates from induced cells
(Figure 2d). Fragments from the ND3 gene (e.g. ND3.4),
or others which were negative for binding in vitro using
EMSA, gave either very faint signals or no signal at all
after immunoprecipitation. Overall, these ﬁndings are
consistent with the proposition that mTERF, when
overexpressed, can bind in vivo to speciﬁc, non-canonical
binding sites, which correspond with binding sites detected
in vitro.
Replication pause sites map close to sites of mTERF
binding in human mtDNA
In previous studies using 2DNAGE we noted the
occurrence of a number of stereotypic pause sites in
mitochondrial DNA of both sea urchins (38) and
vertebrates (21,24). In sea urchins, pause sites corres-
pond with sites of speciﬁc protein binding (39–41). We
therefore considered the hypothesis that some of the
replication pause sites in human mtDNA may map to
locations of mTERF binding.
We initially analysed the region of the genome in which
the canonical mTERF-binding site in the tRNALeu(UUR)
gene is located. 2DNAGE analysis of the PvuII–AccI
fragment covering this site, extending from OL into the
rDNA, in several diﬀerent cell lines and tissues (Figure 3),
revealed a number of pause sites of varying prominence.
To visualize their positions more clearly we treated
parallel samples with S1 nuclease, thus digesting partially
degraded RITOLS intermediates, including any attached
RNA tails. The two epithelia-derived cell-lines, HEK293T
and HeLa, gave very similar patterns, with a clear,
though relatively weak pause site signal in the region
of the tRNALeu(UUR) gene (designated ‘a’ in Figure 3b),
a second, more prominent pause located in the 30 part
of the ND1 gene or in the adjacent IQM tRNA cluster
(designated ‘b’), a third, near OL (designated ‘d’), and
accumulated material in a broad region of ND2
(designated ‘c’).
In 143B (osteosarcoma) and Jurkat (T-cell leukaemia)
cells the steady-state abundance of all mtDNA RIs was
quantitatively less, though the patterns were qualitatively
similar to those seen in HEK293T or HeLa cells.
In S1-untreated material the pause sites were poorly
resolved, and the descending segment of the Y-arc was
very weak. Region ‘c’ was not seen as a discrete species,
even after S1 treatment. Following S1 treatment, the ratio
of the other pauses diﬀered between cell-types: for
example, pause ‘b’ was much more prominent than
pause ‘d’ in Jurkat cells, whereas in 143B cells they were
at similar abundance. The tRNALeu(UUR) gene pause ‘a’
was seen clearly in all cell-lines tested.
In tissue samples (Figure 3c), pause ‘a’, near to the
canonical mTERF-binding site, was most prominent
in the brain, but weak in other tissues tested. Pause ‘d’
was more prominent than pause ‘b’ in heart and brain,
but weaker than pause ‘b’ in skeletal muscle and in
kidney. Pause ‘c’, was seen only in kidney, where both
it (and pause ‘b’) appeared to be even more diﬀuse
than in other tissues or cell-lines. An additional pause
site was seen in brain, between ‘c’ and ‘d’ (denoted ‘d’).
Pause ‘d’, near OL, was also detected as an extended
pause region in human placenta [(24), Supplementary
Figure 3].
Pausing near two other sites at which mTERF binding
to DNA was seen both in vitro and in vivo (Figure 2),
namely OH and the TAS region, is already well
documented from previous studies, and further examples
are seen in Figure 4 (see also Supplementary Figures 3
and 4). Although originally proposed as a unique
unidirectional origin, recent data indicate that OH also
functions as a site of fork arrest when bidirectional
replication initiates elsewhere, and may thus also be
considered as the terminus of replication [(20–22,24), see
also Supplementary Figure 3]. The TAS region is, by
deﬁnition, adjacent to the termination site for the
synthesis of D-loop 7S DNA.
mTERF overexpression enhances replication pausing in
human mtDNA
In order to test whether the level of mTERF expression
inﬂuences replication pausing we carried out 2DNAGE
(E) Summary of EMSA results combining the data from this ﬁgure, Supplementary Figure 2, and other (negative) data not shown. The regions of the
genome which were probed are reproduced from part (a) of the two ﬁgures, plus the ND5-ND6 gene junction which was probed using a dsDNA
oligonucleotide. Binding is denoted as strong (ﬁlled circles), moderate (grey circles), weak (open circles), questionable (dotted circle, fragment OH5,
as discussed in the text and legend to Supplementary Figure 2) or absent (no circles). Our inference of binding is based on the fact that EMSA signals
were enhanced by induction of expression of both mTERF and mTERF-MycHis, that the complexes migrated at slightly diﬀerent positions
consistent with the presence of the epitope tag in the latter case, and that the complexes formed by mTERF-MycHis were supershifted by the anti-
Myc antibody. The assertion that binding is strong, moderate or weak is based either on actual competition experiments (OH1 and ND1.1), or
simply on the strength of the EMSA signal. Where the above criteria were not fulﬁlled, binding was scored as negative. In summary, the ND1 coding
region and following IQM tRNA cluster contain at least four weak binding sites for mTERF. The NCR contains three weak binding sites, as well as
three additional sites which showed very weak or questionable mTERF binding, as shown. A weak binding site was also found in the vicinity of OL.
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analysis of RIs in mtDNA extracted from cells induced to
overexpress mTERF, compared with uninduced cells
(Figure 4, Supplementary Figure 4). Within the 3.6 kb
PvuII–AccI ND2-containing fragment (Figure 4b), pause
site ‘a’ (tRNALeu(UUR), mapping near the canonical site of
mTERF binding) was strongly enhanced by mTERF
overexpression, compared with the unit-length restriction
fragment (denoted 1n in Figure 3d). Pause sites ‘b’ (ND1/
IQM tRNA cluster) and ‘d’ (OL) were also enhanced,
as was the more diﬀuse pause region ‘c’. In mTERF-
overexpressing cells we also detected a more prominent
X-form intermediate (designated ‘x’ in Figure 4b,
Supplementary Figure 4a) in restriction fragments
(e.g. HincII or AccI) containing the tRNALeu(UUR) gene
at a central location.
Within the NCR mTERF overexpression enhanced the
abundance of a paused intermediate migrating near or
beneath the bubble arc (designated ‘f’ in the HincII
fragment and ‘n’ in the AccI fragment, OH probe), as well
as the arc leading to it from the unit-length fragment
(Figure 4c, Supplementary Figure 4b). These forms were
sensitive to S1 nuclease (Supplementary Figure 4b) and are
probably equivalent to the classical D-loop. mTERF
overexpression also appeared to increase the relative
amount of 7SDNAas well as introducing subtle alterations
to the various forms of mtDNA resolved on 1D gels
(Supplementary Figure 4f). mTERF overexpression also
diminished the relative abundance of termination inter-
mediates (designated ‘t’ in Figure 4c and d) and increased
that of Y-form intermediates in which a single fork appears
to have paused when approaching OH (designated ‘g’). The
distribution of material on the termination arc also
appeared to be subtly diﬀerent from that of uninduced cells.
In other regions, a prominent pause site (‘h’, Figure 4c),
located near to the ND5/ND6 gene boundary, was
unaﬀected by mTERF overexpression, whereas a novel
pause was induced in the coding region of ND3
(Supplementary Figure 4c). Note, however, that strong
mTERF binding was not found in vitro in either region
(Supplementary Figure 2 and other data not shown).
Digestion of mtDNA from mTERF-overexpressing
cells with restriction enzymes having only a single
recognition sequence in the genome generated 2DNAGE
patterns consistent with enhanced pausing in the
region of ND1/tRNALeu(UUR) and consequent delayed
resolution in the NCR (Figure 4d, Supplementary
Figure 4d and e). Note that mTERF overexpression
produced subtle, site-speciﬁc eﬀects, rather than a
general slowing of replication e.g. as would be attributable
due to non-speciﬁc stalling.
mTERF knockdown diminishes replication pausing
in the ND1/tRNALeu(UUR) region
To test whether the modulation of replication pausing
resulting from mTERF overexpression represents the
signature of a ﬁnely tuned physiological process rather
than just an overexpression artefact, we downregulated
the expression of mTERF by RNA interference. This
produced a reciprocal eﬀect on mtDNA replication
pausing at the canonical mTERF-binding site. We ﬁrst
tested several diﬀerent mTERF-directed siRNAs in
transient transfection assays, using cells stably transfected
with the mTERF-MycHis expression construct, enabling
us to evaluate knockdown at the protein level by western
blotting (Figure 5a). One particular siRNA (mTERF.1)
gave consistently strong knockdown, as judged also by
immunocytochemistry on mTERF-MycHis-expressing
cells (Figure 5b) and EMSA (Figure 5c). Based crudely
on the autoradiographic EMSA signals, functional
knockdown of >90% was routinely achieved 48 h after
transfection with siRNA mTERF.1. The eﬀects of
mTERF knockdown on replication pausing in the ND1/
tRNALeu(UUR) region were then studied using 2DNAGE
(Figure 5d). Pause site ‘a’ (tRNALeu(UUR)) was no longer
detectable, even on long autoradiographic exposure, and
the prominence of X-forms was also diminished by
mTERF knockdown. The abundance of other pauses
was altered less substantially, though the relative
amount of species ‘b’ compared with ‘c’ appeared to be
decreased.
mTERF overexpression enhances lagging strand 5’ ends
near to specific replication pause sites
One signature of increased replication pausing during
strand-coupled DNA replication should be the enhance-
ment of persistent, lagging strand 50 ends adjacent to
pause sites (Supplementary Figure 5). We used LM-PCR
to map such ends in the vicinity of the major pauses
regulated by mTERF, and to determine the eﬀects upon
them of mTERF overexpression. Comparing mtDNA
from cells overexpressing mTERF with that from unin-
duced cells, we analysed 50 ends on the L-strand near the
canonical tRNALeu(UUR) binding site, as well as in the
whole of ND1 and the adjacent tRNA genes, and also on
the H-strand in the NCR. A cluster of L-strand 50 ends in
or adjacent to the tRNALeu(UUR) gene, notably at np 3211,
Table 1. SELEX analysis of the mTERF-binding site
Position 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Occurrencesa
A 0 0 0 3 30 17 23 21 1 0 0 0 0 2
C 0 0 0 7 4 6 1 3 0 0 15 0 0 0
G 8 43 43 2 4 16 6 16 31 0 0 43 43 0
T 35 0 0 31 5 4 13 3 11 43 28 0 0 41
Consensusb t G G t a r a r g T Y G G t
aOut of 43 clones analysed which matched a clear consensus (see text).
bNucleotides found in 43/43 clones shown in upper case, others in lower case, Y=pyrimidine, R=purine.
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3234 and 3310, were strongly enhanced during 72 h of
induction of mTERF overexpression (Figure 6a,
Supplementary Figure 5b). In the vicinity of the IQM
tRNA gene cluster, LM-PCR revealed L-strand 50 ends
enhanced by mTERF overexpression at np 4476 (close to
the 50 end of ND2 mRNA) and np 4434 (within the
tRNAMet gene), against a background of heterogeneous 50
ends that were generally unaﬀected by mTERF over-
expression (Figure 6b and c). The signiﬁcance of this
heterogeneous background of abundant 50 ends is unclear,
although the two sites enhanced by mTERF overexpres-
sion lie in the vicinity of pause ‘b’. Within the remainder of
the ND1 and ND2 coding regions (Supplementary
Figure 5c–h) we detected only weak LM-PCR signals
which were not aﬀected by mTERF overexpression. The
prominent 50 ends in the tRNACys gene adjacent to OL
were also unaﬀected by mTERF overexpression.
In the NCR, H-strand 50 ends at OH, as well as those
clustered in the distal region of the D-loop (np 16 311,
16 337, 16 370, 16 411 and more weakly at np 16 197) were
strongly induced by mTERF overexpression. This is
consistent with delayed resolution, arising from more
frequent pausing at the canonical mTERF-binding site.
H-strand 50 ends in the NCR are on the lagging strand for
initiation events outside of the NCR, and thus may also be
enhanced by pausing of replication forks entering the
NCR from the ‘cytochrome b side’.
DISCUSSION
mTERF is a modulator of replication as well as transcription
In this study, we showed that mTERF binding at its
canonical binding site in the tRNALeu(UUR) gene
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inﬂuences replication pausing near to this site.
Overexpression of mTERF enhanced this pausing and
increased the steady-state abundance of lagging strand 50
ends adjacent to the binding site, whereas mTERF
knockdown by RNA interferences decreased pausing in
the tRNALeu(UUR) gene region. In addition, based on
studies in vitro (EMSA, SELEX) and supported by
ﬁndings in vivo (mIP), we identiﬁed novel sites of
mTERF binding, elsewhere in the genome. Binding at
these sites was weaker than in the tRNALeu(UUR) gene, but
replication pausing in these regions was nevertheless
inﬂuenced by mTERF overexpression. The data support
a role for mTERF as a modulator of replication, especially
at its canonical binding site. Close parallels with the
properties of replication pause-region binding proteins in
bacteria and eukaryotic nuclei provide some intriguing
hypotheses which we now discuss.
mTERF binding to additional sites in human mtDNA
The present study revealed novel sites of mTERF binding
in the NCR and ND1 gene. mIP assays were consistent
with binding at least at some of these sites by over-
expressed mTERF in vivo. mTERF homologues in
invertebrates, such as DmTTF in Drosophila (12) or
DBP in sea urchins (39,41), also have diverse and multi-
ple binding sites, typically demarcating the 30 ends of
oppositely transcribed gene clusters. Although mTERF
binding to the novel binding sites appeared weaker than at
the canonical binding site, many of them are clustered,
suggesting that cooperative binding might promote site
occupancy in vivo, consistent with the results of mIP. The
binding we observed in vivo might also depend on other
mitochondrial nucleoid proteins, including TFAM, as well
as possible post-translational modiﬁcations.
The eﬀects of mTERF overexpression on mtDNA RIs
from the NCR (Figure 4c and d), suggest that mTERF
may interact with this region in vivo to promote fork arrest
at the replication terminus. The termination zone for
mtDNA replication appears not to be a single point (OH),
but an extended region of the NCR (Figure 4c). mTERF
overexpression resulted in increased stalling of replication
forks as they approach OH from the ‘cytochrome b side’.
It also appeared to elevate the abundance of 7S DNA
(Supplementary Figure 4f) and of S1 nuclease-sensitive
species probably equivalent to the classical D-loop
(Figure 4c), consistent with increased pausing in the
TAS region. Protein-binding sites within the TAS region
were previously mapped by in vivo footprinting (42)
and by EMSA (43), and mTERF might be one of the
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proteins involved. The D-loop remains enigmatic.
DNA synthesis arrest at TAS might be a switching
mechanism relevant to copy number control, or may
have other purposes, such as mitochondrial nucleoid
organization (44).
The Escherichia coli Tus protein, which regulates the
termination of chromosomal DNA replication, may
represent a useful paradigm for mTERF. Tus binds
multiple copies of the Ter sequence ﬂanking the termi-
nator region, and acts directionally as a contrahelicase
(45) to trap replication forks in this region (46). The sea
urchin mTERF homologue DBP has also been shown to
function as a contrahelicase in vitro (15). Like Tus,
mTERF binding to sites on both sides of the replication
terminus region might regulate the entry of oppositely
moving replication forks into the region, facilitating their
orderly synopsis. Increased mTERF expression resulted in
elevated levels of persistent H-strand 50 ends in the NCR
(Figure 6d), an expected signature of delayed resolution
if fork passage through rDNA is more restricted. The
orientation of potential mTERF-binding sites in the
genome appears highly non-random. Taking the simpliﬁed
sequence GG(N8)GG as the minimal binding site, its 12
occurrences in the NCR all bear the same orientation. The
same applies to the cluster of seven such sites in the 30
portion of ND1 and the adjacent tRNA gene cluster. In
contrast, the canonical binding site shows the opposite
orientation, although is ﬂanked on each side by two
oppositely oriented copies of the minimal binding site
(Supplementary Figure 6).
Although we detected only ambiguous mTERF binding
in vitro in the H-strand transcriptional initiator region,
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(directed against mTERF mRNA) and siRNA Control. HEK293T cells were either untransfected (), transiently transfected (t) or stably (+)
transfected with an mTERF-MycHis expression construct. Cells were then assayed 24, 48 and 72 h following siRNA transfection or else without such
transfection (). The arrowed band is the mTERF-MycHis fusion protein, migrating between two background bands which appear in all westerns
and thus provide an internal loading control. Note that the sample from untransfected, non-siRNA-treated cells in the upper panel (penultimate lane)
is approximately 3-fold overloaded. (B) Immunocytochemistry of HEK293T cells stably transfected with mTERF-MycHis expression construct and
then either mock transfected or transiently transfected with siRNA mTERF.1. Immunocytochemistry used the anti-Myc monoclonal antibody, and
counterstaining with Mitotracker Red. (C) EMSA using Leu-short dsDNA oligonucleotide probe and mitochondrial protein extracts from HEK293T
cells with or without stable transfection of mTERF-MycHis expression construct, followed by transient transfection for 48 h with or without siRNA
mTERF.1. Despite the apparent diﬀerence in signal, the experimental conditions are the same as in Figure 1c: only the exposure time is diﬀerent, and
the amount of background signal in the gel. (D) 2DNAGE of mtDNA from untreated HEK293T cells or cells transfected with siRNA mTERF.1 for
48 h. PvuII + AccI digest (S1 treated) probed for the 3.6 kb fragment using ND2 probe. Panels iii and iv are longer exposures of panels i and ii,
respectively. Note the down-regulation of the X-spike (‘x’) and pause site ‘a’, as well as of pause site ‘b’ relative to pause region ‘c’ (see Figure 3).
(E) Phosphorimager-calibrated exposures of 2DNAGE blots from siRNA-treated cells (panel iii) alongside the corresponding images (panels i and ii)
from uninduced and induced mTERF over-expressing cells, reproduced from Figure 4b. A longer exposure (panel iv) conﬁrms the absence of pause ‘a’.
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(Supplementary Figure 2e, EMSA probe OH5), mIP
ﬁndings suggest that the site is eﬃciently bound in vivo
by overexpressed mTERF. The latter is consistent with
previous ﬁndings that recombinant mTERF (7,29) binds
only weakly to this site, whereas partially puriﬁed,
endogenous mTERF binds more strongly and establishes
a DNA loop required for eﬃcient rDNA transcription (7).
This may require a post-translational modiﬁcation or
limiting accessory factor found only in vivo. mTERF exists
in multiple isoforms with distinct properties (4,47), and
has been reported to convert to an inactive trimeric form
in vitro (48). The initiator fragment also contains binding
sites for TFAM, which may promote binding but may also
interfere with the interpretation of the EMSA assay (see
Supplementary Figure 2e).
Regulated passage of replication and transcription complexes
The role of mTERF as a transcriptional terminator
is well established from in vitro studies, and DmTTF
also functions thus in vivo in Drosophila (13).
However, there is no compelling evidence that mTERF
regulates mitochondrial RNA levels physiologically.
The disparity in relative abundance between mRNAs
and rRNAs in mammalian mitochondria can largely
be accounted for by post-transcriptional regulation,
notably diﬀerences in half-life (49) and RNA processing
eﬃciency (50). Despite causing reduced mTERF-binding
aﬃnity and terminator activity in vitro, the 3243A>G
MELAS mutation has almost no eﬀect on mitochondrial
RNA levels in vivo (5). Moreover, manipulation of
mTERF levels in vivo by overexpression or RNA
interference has remarkably little eﬀect on steady-state
mitochondrial RNA levels (Hyva¨rinen et al., manuscript
in preparation). The observation that mTERF also
modulates mtDNA replication pausing suggests a diﬀer-
ent physiological meaning for its action as a transcrip-
tional terminator, i.e. it coregulates replication and
transcription.
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The unregulated collision of oppositely moving tran-
scription and replication complexes drastically inhibits
DNA replication and provokes genomic instability in both
bacteria (51,52) and yeast (53,54). In E. coli, head-on
collision of the transcription and replication machineries
severely impedes the progress of the replication fork (51)
whereas codirectional transcription has no eﬀect. Within
the E. coli chromosome almost all essential genes are
oriented such that transcription and replication are
codirectional (55), which is proposed to minimize the
mutagenic eﬀect of repeated replication stalling and
recombinational restart, following head-on collisions
(51,56). In bacterial or yeast plasmids, or yeast rDNA,
such head-on collisions can trigger genomic instability
(53,57,58), e.g. due to knotting of daughter duplexes (59).
In mammalian nuclei, head-on collisions can trigger the
formation of HSRs (homogeneously staining regions of
chromosomes), the signature of massive gene ampliﬁca-
tion events (60).
Proteins with dual roles in replication and transcrip-
tional arrest are well documented. The E. coli Tus protein,
described in the preceding section, preferentially blocks
transcription with a similar polarity as DNA replication
(61,62). Passage of a transcription complex from the
permissive direction relieves the block on DNA synthesis
(61) by provoking the dissociation of bound Tus (63). The
mouse TTF-I protein binds at the 30 end of the rDNA
transcription unit, where it terminates transcription by
RNA polymerase I (64) and arrests replication forks
arriving from the other direction (65,66), via its polar
contrahelicase activity (67). This organization of the
rDNA locus is relatively conserved throughout eukary-
otes, although in some species the TTF-I homologue
co-operates with or depends upon other proteins to
maintain the replication fork barrier (RFB), including
Sap1p and Reb1p in Schizosaccharomyces pombe (68–70),
with involvement of Swi1p and Swi3p to stabilize the
stalled forks (71), or Fob1p in Saccharomyces cerevisiae
(72,73), with Sir2p regulating recombination at the stalled
forks (74).
The entry of replication forks into the mtDNA
termination zone around OH requires traversal of the
heavily transcribed rDNA region in the antisense direc-
tion, with potentially catastrophic consequences if a
transcription complex is encountered. By binding at the
rDNA boundary, mTERF may thus serve a function
related to those of both Tus and TTF-I, facilitating the
regulated passage of oppositely moving transcription and
replication machineries, and regulating fork access to the
termination zone.
The passage of a transcriptional complex in the
permissive direction may also serve a regulatory role,
such as hypothesized for mtDBP in relieving the block on
D-loop expansion in sea urchins (15).
mTERF overexpression enhanced X-like species in
fragments where the canonical mTERF-binding site was
centrally located (Figure 4b, Supplementary Figure 4a),
whereas mTERF knockdown by RNA interference
depleted such species (Figure 5d). Although these may
be recombination intermediates (see below), they might
also comprise termination complexes centred on the
mTERF-binding site. If increased mTERF activity
enhances rDNA transcription (6), it may also restrict the
entry of replication forks into rDNA in the antisense
direction and perhaps even shift the resolution site in some
molecules from the NCR to the tRNALeu(UUR) gene.
However, this must be a very minor fraction of molecules,
since we did not see a complete Y-arc in OH-containing
fragments.
Transcription termination and the bootlace model
Previous studies of vertebrate mtDNA replication indi-
cated that, in the majority of molecules, the lagging strand
is initially laid down in the form of extended RNA
segments which are subsequently converted to DNA via a
maturation step (19). We hypothesized that the RNA
lagging-strand may arise via either of two highly
unorthodox mechanisms: either via a primase capable of
synthesizing extended RNA primers, or by the hybridiza-
tion of preformed L-strand RNA with the displaced
H-strand in a 30 to 50 direction as the replication fork
advances, the so-called bootlace model.
mTERF-dependent replication pausing may be con-
strued as circumstantial evidence supporting the bootlace
model. Transcriptional termination by mTERF adjacent
to a paused replication complex would provide a 30 end
capable of priming lagging-strand DNA synthesis, at the
same time as delivering a fresh RNA bootlace to enable
the replication fork to proceed in the forward direction.
The mTERF-dependent enhancement of lagging strand
50 DNA ends near the canonical (and some other)
mTERF-binding sites, (Figure 6), supports this idea.
In sea urchin mtDNA, the major replication pause-
region, which interacts with at least two DNA-binding
proteins (38,40,41), also appears to be a major lagging-
strand origin, as well as a site of transcriptional
termination and/or RNA processing.
The eﬀect of overexpression of mTERF is much more
site-speciﬁc than that produced by overexpression of
TFAM (28), by treatment with mtDNA replication
inhibitors such as dideoxycytidine (28), or by expression
of dominant-negative versions of the mtDNA helicase
Twinkle (31). Unlike these treatments, mTERF over-
expression did not cause a general slowing of replication,
and did not alter globally the ratio of strand-coupled and
RITOLS type RIs. By facilitating lagging-strand matura-
tion, mTERF may serve merely to minimize the extent of
the region of mtDNA maintained in the more vulnerable
RNA-DNA hybrid form, thus contributing to genome
stability.
Recombination at the mTERF-binding site
An alternate interpretation of the X-like molecules centred
on the tRNALeu(UUR) gene region, which were enhanced
by mTERF overexpression and depleted by mTERF
knockdown, is that they represent true recombination
intermediates. Such forms would be expected to arise if
persistent mTERF binding and consequent prolonged
pausing entrain fork collapse, requiring either a double-
strand break or fork regression to generate a recombino-
genic end for restart of replication. We previously
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noted that the canonical mTERF-binding site was a
frequent break-point in rearranged mtDNA molecules
(‘sublimons’) detectable at a low level in all cell-types,
but especially prominent in human heart (75), and also in
mice expressing a disease-equivalent version of the
Twinkle helicase(76) associated with autosomal dominant
external ophthalmoplegia (PEO). It is tempting to ascribe
such molecules to aberrant recombination following
pausing and fork collapse at the tRNALeu(UUR) gene.
In yeast, double-strand breaks at the site of the RFB in
rDNA, giving rise to low-level genomic rearrangements
implicated in ageing, are evident even in wild-type strains
(54). However, in strains defective for the DNA helicase
Rrm3p, which is required for the processing of paused
replication forks at sites of protein binding (77,78), the
frequency of such events is greatly increased. If the
balance between the pause-inducing and pause-processing
machineries is disturbed, recombinational mechanisms
must be employed to restart replication, with the
concomitant risk of genomic instability. Thus, even
though replication pausing systems such as mTERF may
have evolved to limit genomic instability by preventing
collisions of the replication and transcription machineries,
their dysregulation, including by overexpression, could
itself lead to instability. It follows that mTERF is a
candidate gene for involvement in those cases of genetic
disorders mediated by mtDNA rearrangements (e.g.
PEO), whose genetic basis has not yet been elucidated.
In some cases replication pausing is merely a signature
of defective replication (79,80). In others it is clearly a
programmed event which facilitates other processes and
preserves genome stability (81). As indicated by our
ﬁndings (Figure 3), the phenomenon of pausing in human
mtDNA is not conﬁned to just one cell-type, nor is it an
in vitro artefact seen only in cultured cells. The fact that it
exhibits diﬀerences between cell-types and tissues strength-
ens the proposition that it is of physiological signiﬁcance.
The involvement of mTERF in modulating mtDNA
replication pausing in human mtDNA, and the analogies
with programmed replication pausing in other systems,
support the idea that mTERF represents a system for
safeguarding the integrity of the mitochondrial genome,
whilst facilitating its eﬃcient expression.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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